Conserved Streptococcus pneumoniae protein antigens

Conserved Streptococcus pneumoniae protein antigens are a diverse group of surface-exposed and secreted proteins that play critical roles in the pathogenesis and virulence of the pneumococcus. Unlike the capsular polysaccharides used in current conjugate vaccines, these proteins are highly conserved across the more than 100 known serotypes of S. pneumoniae, making them attractive targets for the development of serotype-independent or "universal" pneumococcal vaccines (Frontiers in Immunology, 2022; NIH/PubMed, 2019). Key antigens in this class include Pneumococcal surface protein A (PspA), which inhibits complement activation; Pneumolysin (Ply), a potent pore-forming toxin; and the Polyhistidine triad proteins (PhtD and PhtE), which are involved in metal ion homeostasis and immune evasion (ASM/Infection and Immunity, 2021; NIH/PubMed, 2014). Therapeutic strategies targeting these antigens include protein-based subunit vaccines, such as GSK's PhtD/dPly candidate (GSK2189242A) and Affinivax's Multiple Antigen Presenting System (MAPS) platform (ASP3772), as well as experimental human monoclonal antibodies like PhtD3 (NIH/PubMed, 2022; ClinicalTrials.gov, 2015). These interventions aim to elicit robust opsonophagocytic antibodies and T-cell-mediated immunity, particularly Th17 responses, to prevent nasopharyngeal colonization, reduce bacterial burden in the lungs and blood, and neutralize essential virulence factors (MDPI, 2022; BioRxiv, 2022). By targeting conserved proteins, these therapies seek to overcome the limitations of current vaccines, such as serotype replacement and the emergence of non-vaccine serotypes.

Other names

Pneumococcal protein antigensConserved pneumococcal surface proteinsNon-capsular pneumococcal antigensPneumococcal surface proteinsSpecies-specific pneumococcal antigens

Induction of opsonophagocytic antibodies and T-cell-mediated immunity (specifically Th17 responses) to neutralize virulence factors, inhibit bacterial adhesion to host tissues, and promote complement-mediated clearance of the pathogen.